AARHUS, Denmark: Danish medtech company Unisense FertiliTech A/S announces a new partnership with the Danish Pension Fund PKA. PKA owns 25% of Unisense FertiliTech A/S after the purchase of shares in the company worth 20 million USD. This brings the total of new investment in the company over the past 3 months to 45 million USD.
Unisense FertiliTech A/S develops and manufactures products to improve treatment in the field of assisted reproduction. The company has expanded rapidly in the past 2 years, operating in more than 30 countries worldwide. In addition to the current hardware and software product offerings, there is an exciting pipeline of products under development which hold significant commercial potential within the IVF industry. With this additional investment, the company will be in an excellent position to execute its long term development strategy and to accelerate the global expansion of sales of FertiliTech's existing and new products geared towards improving clinical practice in the field of IVF.
Investment Director at PKA, Michael Nellemann Pedersen states "FertiliTech has created a unique product with a rapidly growing global demand. This demand is expected to continue, with a worldwide increased trend to a higher age of first time mothers. We feel this is an extremely exciting investment opportunity with a promising future."
"We very much look forward to the cooperation with PKA, who with this long term investment contributes positively to create stability in the ownership of Unisense FertiliTech," says Unisense FertiliTech A/S CEO, Jens Gundersen.
About Unisense FertiliTech A/S
Unisense FertiliTech A/S was founded in 2003 and has developed and manufactures state-of-the-art instrumentation in the field of IVF. The current products include the EmbryoScope® Time-lapse system, the EmbryoViewer® Software and related accessory products, which are EU approved and FDA cleared for clinical use in IVF laboratories. Unisense FertiliTech A/S conforms to the requirements in DS/EN ISO 13485:2012 for production, installation and servicing of IVF incubators and related accessories
The company is involved in numerous international collaborations, and strives to develop embryo assessment algorithms to improve embryo selection and workflow in the assisted reproduction laboratory. Our goal is to promote knowledge building through extensive documentation and retrospective analysis. We are dedicated to providing technology to improve IVF treatment through quantification of embryo development patterns.
About PKA:
PKA is a joint administration for five Danish pension funds with a total of 250,000 members. They control funds of USD 35 billion.
Website: http://www.fertilitech.com
SOURCE Unisense Fertilitech A/S
